In this study, we performed germline mutation analysis of the entire coding region of PALB2 in a cohort of 1996 breast cancer index cases referred to familial cancer clinics for genetic testing and tested negative for BRCA1 and BRCA2 mutations as well as 1998 Australian cancer-free female controls. This evidence concerns the gene BRCA2 and cancer.